Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-04

Clinical Trial Update: Nicergoline Use in Dysphagia Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating nicergoline for dysphagia has completed; the update does not include efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicergoline (nicergoline)

Snippet

Sponsor: Phramongkutklao College of Medicine and Hospital | Conditions: Dysphagia | Phase 3 | Status: COMPLETED